FLLL12 is a Curcumin analogue which exhibits enhanced growth-suppressive activity and inhibits AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells. References: Anisuzzaman AS, Haque A, Rahman MA, Wang D, Fuchs JR, Hurwitz S, Liu Y, Sica G, Khuri FR, Chen ZG, Shin DM, Amin AR. Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers. Cancer Prev Res (Phila). 2016 Jan;9(1):63-73. doi: 10.1158/1940-6207.CAPR-15-0240. Epub 2015 Oct 28. PubMed PMID: 26511491; PubMed Central PMCID: PMC4706799.

纯度：≥98%